These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 30367738)

  • 1. Metabolism and elimination of the catechol-o-methyltransferase inhibitor tolcapone in the horse.
    Stanley S; Van den Berg K; Foo HC; Deng D
    Drug Test Anal; 2019 Apr; 11(4):578-585. PubMed ID: 30367738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism and excretion of tolcapone, a novel inhibitor of catechol-O-methyltransferase.
    Jorga K; Fotteler B; Heizmann P; Gasser R
    Br J Clin Pharmacol; 1999 Oct; 48(4):513-20. PubMed ID: 10583021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection and confirmation of ractopamine and its metabolites in horse urine after Paylean administration.
    Lehner AF; Hughes CG; Harkins JD; Nickerson C; Mollett B; Dirikolu L; Bosken J; Camargo F; Boyles J; Troppmann A; Karpiesiuk WW; Woods WE; Tobin T
    J Anal Toxicol; 2004; 28(4):226-38. PubMed ID: 15189672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The disposition of the tolcapone 3-O-methylated metabolite is affected by the route of administration in rats.
    Funaki T; Onodera H; Ushiyama N; Tsukamoto Y; Tagami C; Fukazawa H; Kuruma I
    J Pharm Pharmacol; 1994 Jul; 46(7):571-4. PubMed ID: 7996385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of the catechol-O-methyltransferase inhibitor tolcapone and three of its metabolites in animal and human plasma and urine by reversed-phase high-performance liquid chromatography with ultraviolet detection.
    Heizmann P; Schmitt M; Leube J; Martin H; Saner A
    J Chromatogr B Biomed Sci Appl; 1999 Jul; 730(2):153-60. PubMed ID: 10448949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of tolcapone, a novel catechol-O-methyltransferase inhibitor, on striatal metabolism of L-dopa and dopamine in rats.
    Napolitano A; Zürcher G; Da Prada M
    Eur J Pharmacol; 1995 Feb; 273(3):215-21. PubMed ID: 7737328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of metabolite profiles of the catechol-O-methyl transferase inhibitor tolcapone in rat urine using LC/MS-based metabonomics analysis.
    Sun J; Von Tungeln LS; Hines W; Beger RD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Aug; 877(24):2557-65. PubMed ID: 19615953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The equine metabolism of the catechol-O-methyltransferase enzyme inhibitor nitecapone.
    Stanley S; Deng D; Van den Berg K; Foo HC
    Drug Test Anal; 2022 May; 14(5):929-935. PubMed ID: 34545698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of an effect of Madopar on the disposition of tolcapone and its 3-O-methylated metabolite in rats.
    Funaki T; Onodera H; Ushiyama N; Tsukamoto Y; Tagami C; Fukazawa H; Kuruma I
    J Pharm Pharmacol; 1995 Jun; 47(6):539-42. PubMed ID: 7674141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening of chlorpropamide in horse plasma by high-performance liquid chromatography with ultraviolet absorbance detection, and confirmation by gas chromatography-mass spectrometry.
    Chua HC; Stewart B; Lim BH; Lee HK
    J Chromatogr B Biomed Sci Appl; 1998 Aug; 712(1-2):243-52. PubMed ID: 9698247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of the catechol-O-methyltransferase inhibitor Ro 40-7592 in human plasma by high-performance liquid chromatography with coulometric detection.
    Timm U; Erdin R
    J Chromatogr; 1992 Feb; 593(1-2):63-8. PubMed ID: 1639913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid chromatography-mass spectrometry analysis of five bisphosphonates in equine urine and plasma.
    Wong AS; Ho EN; Wan TS; Lam KK; Stewart BD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Aug; 998-999():1-7. PubMed ID: 26143477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacology, therapeutic use and potential of COMT inhibitors in Parkinson's disease.
    Kaakkola S
    Drugs; 2000 Jun; 59(6):1233-50. PubMed ID: 10882160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intracerebral 6-nitronoradrenaline, an endogenous catechol-O-methyltransferase (COMT) inhibitor, on striatal dopamine metabolism in anaesthetised rats.
    Huotari M; Passlin M; Nordberg HL; Forsberg M; Kotisaari S; Tuomisto L; Shintani F; Tanaka KF; Reenilä I; Laitinen K; Männistö PT
    J Neurosci Methods; 2001 Aug; 109(1):47-52. PubMed ID: 11489299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No change of brain extracellular catecholamine levels after acute catechol-O-methyltransferase inhibition: a microdialysis study in anaesthetized rats.
    Li YH; Wirth T; Huotari M; Laitinen K; MacDonald E; Männistö PT
    Eur J Pharmacol; 1998 Sep; 356(2-3):127-37. PubMed ID: 9774242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection, pharmacokinetics, and selected pharmacodynamic effects of methamphetamine following a single transmucosal and intravenous administration to exercised Thoroughbred horses.
    Knych HK; Arthur RM; Kanarr KL; McKemie DS; Kass PH
    Drug Test Anal; 2019 Sep; 11(9):1431-1443. PubMed ID: 31218824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and pharmacokinetics of tetrahydrogestrinone in horses.
    Machnik M; Gerlach M; Kietzmann M; Niedorf F; Thevis M; Schenk I; Guddat S; Düe M; Schänzer W
    J Vet Pharmacol Ther; 2009 Apr; 32(2):197-202. PubMed ID: 19290951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of tolcapone in the cerebrospinal fluid of parkinsonian subjects.
    Russ H; Müller T; Woitalla D; Rahbar A; Hahn J; Kuhn W
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Dec; 360(6):719-20. PubMed ID: 10619191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple-dose clinical pharmacology of the catechol-O-methyl-transferase inhibitor tolcapone in elderly subjects.
    Dingemanse J; Jorga K; Zürcher G; Fotteler B; Sedek G; Nielsen T; van Brummelen P
    Eur J Clin Pharmacol; 1996; 50(1-2):47-55. PubMed ID: 8739811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic study of androsta-1,4,6-triene-3,17-dione in horses using liquid chromatography/high resolution mass spectrometry.
    Kwok WH; Leung GN; Wan TS; Curl P; Schiff PJ
    J Steroid Biochem Mol Biol; 2015 Aug; 152():142-54. PubMed ID: 26031748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.